Yüklüyor......
Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
We have previously conducted a phase I trial to test the efficacy of a glypican-3 (GPC3) peptide vaccine in patients with advanced hepatocellular carcinoma (HCC); however, its immunological mechanism of action remains unclear. Here, we report a pilot study conducted to evaluate the immunological mec...
Kaydedildi:
| Yayımlandı: | Oncoimmunology |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5665076/ https://ncbi.nlm.nih.gov/pubmed/29123959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1346764 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|